$CapLand IntCom T(C38U.SI)$ always good to accumulate some during the dips. Stable dividends and potential for capital gains. This is a leader among S Reits.
$Pfizer(PFE)$ Pfizer: Down 19% Pfizer has been a big name in healthcare for decades, but it has been a largely underwhelming investment over the past 10 years, falling by more than 19% during that time frame. The company has been dealing with patent expirations and needing to innovate to continue growing. Things were looking good a few years ago when its COVID vaccine and pill resulted in its business achieving record numbers, with sales topping more than $101 billion in 2022. But with that no longer being a key growth catalyst for the business anymore and Pfizer now also worrying about government cutbacks on healthcare spending, investors haven't been eager to buy the stock, even despite its modest 18 times ear
Dow vs. DuPont: Which Chemical Giant Looks Like the Better Buy Today?
$Dow Chemical(DOW)$$DuPont de Nemours Inc(DD)$ Dow Inc. (DOW) and DuPont de Nemours, Inc. (DD) are two of America’s most prominent chemical manufacturers, each producing a diverse range of chemicals and materials for a wide spectrum of industries. Both companies share a rich, intertwined history, most notably their high-profile merger in 2017 and subsequent separation into independent publicly traded entities in 2019. Today, Dow and DuPont operate as restructured, standalone firms with diversified portfolios serving key end markets like packaging, electronics, construction, automotive, and agriculture. Against a backdrop of demand softness in several segments and the added challenge of trade tariffs, invest
Palantir: The High-Stakes Bet That Could Make (or Break) You
$Palantir Technologies Inc.(PLTR)$ Palantir Technologies (NYSE: PLTR) has been one of the most hotly debated stocks in recent years. For some, it is a high-conviction play on the future of artificial intelligence and data-driven decision-making — a true hero stock poised to deliver exceptional long-term returns. For others, it is little more than speculative hype, trading at valuations detached from reality, with questionable scalability beyond government contracts. In the wake of its recent earnings beat and management’s bullish commentary on its Artificial Intelligence Platform (AIP), investors face a critical question: is Palantir worth adding — or keeping — in a diversified portfolio? Or is this a story stock best avoided at current prices? In
NTT DC REIT IPO: Prospectus & Summary, comparison with existing Data Centre REITs
Overview NTT DC REIT is launching Singapore’s largest real estate investment trust (REIT) IPO in over a decade, seeking to raise approximately US$773 million. The offering comprises 599.9 million units priced at US$1.00 per unit for institutional and international investors, and 30 million units at S$1.276 for the Singapore public. NTT Limited, the sponsor, will retain a 25% stake through a concurrent subscription of 257.6 million units, while GIC, Singapore’s sovereign wealth fund, emerges as a key cornerstone investor with a 9.8% stake. The REIT's cornerstone investors also include AM Squared, UBS, Hazelview, and others. Trading is expected to commence on July 14, 2025, on the SGX Mainboard. Prospectus | Product Highlights Sheet Fundamental and Financial Ratios Type: Data Centers (Carrie
$110K Bitcoin Is Back! Should You Trade Crypto Stocks Today?
$Riot Platforms(RIOT)$$Coinbase Global, Inc.(COIN)$$MARA Holdings(MARA)$ Bitcoin has done it again. After a long, grinding bear market that tested the patience of even the most hardened hodlers, the world’s largest cryptocurrency is back above $110,000, smashing through its previous all-time highs and reigniting investor excitement across global markets. Crypto bulls are celebrating this milestone as a validation of Bitcoin’s role as both a store of value and a speculative growth asset. Meanwhile, the surge in Bitcoin prices has also sparked a flurry of activity in crypto-related stocks, including miners, exchanges, and blockchain infrastructure plays. But as t
Singapore Banks on Fire: Will UOB or OCBC Be the Next to Soar?
Singapore’s banking sector is stealing the spotlight, with DBS Group Holdings (DBS) smashing an all-time high at ~S$44.46 and Oversea-Chinese Banking Corporation (OCBC) riding a six-day winning streak to ~S$17.07. Investors are now turning their gaze to United Overseas Bank (UOB), wondering if it will be the next to break through to new highs. With record profits, robust dividend yields, and a resilient Singapore economy, these banks are defying global trade tensions. But which one—UOB or OCBC—should you add to your portfolio to catch this rally? This report dives into the catalysts driving Singapore’s banking boom, compares UOB and OCBC’s potential, and outlines strategic investment approaches to maximize gains while navigating risks. UOB Likely to Set New High Next It seems likely that U
Daily Charts - S&P 500 market breadth near the worst level this century
1.S&P 500 $S&P 500(.SPX)$ market breadth near the worst level this century Image2.S&P 500 $SPDR S&P 500 ETF Trust(SPY)$ has traded above its upper Bollinger Band for the past 8 days 🚨 The last time it did that was in July 2024 and then SPY promptly corrected by 10% 📉📉Image3.S&P 500 will fall to 5,500 in the second half of the year warns Stifel 🚨Image4.Ark Innovation ETF $ARK Innovation ETF(ARKK)$ is on track for its 19th consecutive month of outflows 👀Image5.Amazon $Amazon.com(AMZN)$ forms a Golden Cross for the first time since May 2023 🚨 The last one sent shares soaring more than 100% over the next 2
Last time this setup hit on $Alibaba(BABA)$ , it ran +72% 👀We’re pulling back into Monthly Bias — a major discount zone.Volume profile shows support near $90. That’s my reload level.First sign of strength? Weekly BX closing HL ✅ImageFor whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!Find out more here:Trade on a Cash Boost Account and enjoy up to 6 months of Commission-Free trading.💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉💰CBA Mini Course 1: What is Cash Boost Account(CBA)
$Cloudflare, Inc.(NET)$ +61% in 2 months — one of our top runners 🔥Bounced perfectly off Monthly Bias, then flipped Weekly BX into HL.Confirmation came with the BX turning 🟢 — and it’s been straight expansion since.My long bots are still live, but I’ve de-risked heavily.Will fully remove this from watchlist when Weekly BX flips 🔴.ImageFor whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!Find out more here:Trade on a Cash Boost Account and enjoy up to 6 months of Commission-Free trading.💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉
$SoFi Technologies Inc.(SOFI)$ +75% since testing Monthly Bias 💸Textbook setup: Weekly BX flipped HL inside Monthly Bias — a prime discounted zone in bullish structure.Buyers stepped in hard, and SOFI ripped 75% in 3 months.I missed it while focused on other names, but this was by the book 🔥If I were in, I’d be trimming 25% here and letting the rest ride.ImageFor whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!Find out more here:Trade on a Cash Boost Account and enjoy up to 6 months of Commission-Free trading.💰Join the TB Contra Telegram Group to Get $1
How Can We Adjust Our Investment Strategy Amid Trump's Tariff Salvo?
Trump’s latest tariff salvo with blanket duties ranging from 25% to 40% on imports from 14 countries starting 01 August is a jolt to global trade dynamics, inflation expectations, and sector leadership. We saw that on July 8, 2025, the $S&P 500(.SPX)$ experienced a mixed but generally negative reaction to renewed tariff threats from President Donald Trump. After a broad sell-off on July 7, the S&P 500 slipped a further 0.1% on July 8, though it remained near the record high it set the previous week. Here are the breakdown of the market's reaction and the context surrounding it: Key Events and Market Movement: Renewed Tariff Threats: The market reacted to President Trump's announcement of new tariff rates on several countries, including Jap
A Compelling Long-Term Investment in Precision Oncology
Tango Therapeutics (TNGX), a clinical-stage biotechnology company listed on NASDAQ, is poised for significant growth as it advances its innovative pipeline in precision oncology. With a robust cash position, promising clinical trial progress, and strategic partnerships, TNGX presents a compelling case for investors seeking exposure to high-growth opportunities in the biotechnology sector. This article outlines the key reasons to be bullish on TNGX, focusing on its strong fundamentals, technical momentum, and positive catalysts on the horizon. A Leader in Precision Oncology Tango Therapeutics is at the forefront of developing targeted therapies for cancers with specific genetic mutations, leveraging the concept of synthetic lethality to address unmet medical needs. Its lead drug candidates,
Delta Air Lines (DAL) Demand Trends, Cost Control and 2025 Outlook To Watch
$Delta Air Lines(DAL)$ is scheduled to report its fiscal Q2 2025 earnings on Thursday, 10 July 2025, before the market opens. Earnings Per Share (EPS) (Adjusted) : the consensus estimate for earnings per share (EPS) adjusted is expected to come in at $1.92 per share which represent a ↓ 18.6% vs. $2.36 YoY Change. Revenue: the consensus estimate for revenue is expected around ~$16.2B (consensus) which represent a ↓ ~2.9% YoY. The guided EPS range is $1.70 to $2.30 which indicate a broad range due to macro uncertainty. DAL has beaten estimates in 2 of the last 4 quarters but missed in the other two. Delta Air Lines (DAL) Last Neutral Earnings Saw Share Price Up 13.84% Delta Air Lines last neutral earnings call on 09 April 2025 saw its share price up
$Global X Artificial Intelligence & Technology ETF(AIQ)$$First Trust Nasdaq Artificial Intelligence and Robotics ETF(ROBT)$$Defiance Quantum ETF(QTUM)$ 🚀🤖📈 AIQ, QTUM, ROBT: 3 AI ETFs Powering the Smartest Trade on the Screen 📈🤖🚀 This isn’t just about buying the AI narrative. This is about positioning across 3 structurally differentiated ETFs that capture platform scale, deep compute infrastructure, and robotic execution. I’m watching $AIQ, $QTUM, and $ROBT closely because each of them is telling a different story on the chart, and under the hood. 🧠 $AIQ: Global X Artificial Intelligence & Technology ETF AIQ gives me exposure to the AI consumer–enterprise